CH|DE
Select your region & language
Our content and services may vary by location.
CH|DE
Zurück
Lächelnde Mitarbeiterin im Gespräch mit Kollegin im Büro
Lächelnde Mitarbeiterin im Gespräch mit Kollegin im Büro
ID: 1419080

Patient Engagement Manager

  • Pharma & Biotech
  • Asap
  • , Patient Affairs, Advisory Boards, KOL-Management
  • K-Recruiting Schweiz AG
Ansprechpartner:

Julius Strack

+49 89 1890998-21

julius.strack@k-recruiting.com

Overview

Availability
Asap; 5 days/week; remote
Qualification
PhD in Medical Sciences
Language Skills
Dutch (native), English (business fluent), French & Norwegian (fluent)
Relevant Expertise
Patient Engagement, Medical Affairs, Patient Affairs, Advisory Boards, KOL-Management, Immunology, Allergology, Dermatology, Stakeholder Management, Pharma

Key-Facts

  • Established leader in patient and community engagement, with 20 years of experience building advocacy and partnership ecosystems across Europe and North America

  • Proven connector of patient groups, medical societies, and institutions, with long-standing collaboration across advocacy, KOL, and professional networks central to dermatology engagement

  • Demonstrated impact in disease awareness and education, delivering guideline-aligned medical and patient initiatives supporting dermatologists, immunologists, and multidisciplinary teams

  • Founder of a patient engagement function at a pharmaceutical company, integrating patient perspectives into reimbursement dossiers, advisory boards and advocacy ecosystems for high-unmet-need and rare disease contexts

Extract from Previous Activities

2025 – D a t e

Own Company

Senior Patient Engagement Manager

  • Acts as an independent medical and patient engagement expert supporting value recognition of innovative medical technologies

  • Applies long-standing expertise in immunology, hematology, oncology and precision medicine to advise on stakeholder engagement strategies

  • Supports alignment between patient communities, medical experts and institutional stakeholders to cocreate sustainable access and engagement models

  • Leverages extensive European and North American advocacy, medical and policy networks to foster multistakeholder collaboration

2024 – 2024

Pharmaceutical Company, Switzerland

EMEA–LATAM Policy Lead Europe

  • Led policy-focused external engagement addressing systemic healthcare challenges impacting access to innovation

  • Engaged policymakers, medical experts and advocacy stakeholders at European level to shape consensus and policy narratives

  • Translated medical and patient needs into policy-relevant frameworks, supporting long-term sustainability of healthcare systems

  • Strengthened cross-border collaboration across professional and institutional networks

2018 – 2024

Pharmaceutical Company, Switzerland

Strategic Access, Medical & Patient Lead (BE / EU)

  • Served as strategic lead for external engagement across medical, patient, access and policy domains

  • Drove adoption and reimbursement of genomic and liquid biopsy testing for precision medicine through multistakeholder collaboration

  • Founded and led the Patient Engagement function, pioneering patient-inclusive access strategies aligned with unmet medical needs

  • Built and maintained long-term partnerships with patient advocacy organizations, patient experts and umbrella networks (e.g., EURORDIS, EUPATI, IEEPO, BEEPO)

  • Organized and facilitated multi-stakeholder advisory boards with patients, clinicians, payers and policymakers to co-create care pathways and policy roadmaps

  • Acted as trusted liaison between patient communities, medical societies, laboratories and institutional decisionmakers

  • Developed disease awareness, biomarker education and guideline-aligned materials adopted globally

  • Engaged extensively with European and North American medical professional societies and KOL networks

2013 – 2016

Pharmaceutical Company, Switzerland

Scientific Manager North America (US / Canada)

  • Field-based scientific and medical engagement lead in hematology, oncology and immunology

  • Built trusted relationships with clinicians and multidisciplinary hospital teams across 70+ institutions

  • Delivered extensive education and scientific exchange (>100 presentations) supporting best practices and patient-centered care

  • Supported physicians in disseminating clinical experience through conference abstracts and peer-reviewed publications

  • Strengthened collaborative networks between industry, clinicians and academic centers